Atypical respiratory distress in eastern Democratic Republic of the Congo prior to the COVID-19 pandemic. A case report.
COVID-19
Case report
Democratic Republic of the Congo, DRC
Pandemic
SARS-Cov-2 coronavirus
Journal
Tropical diseases, travel medicine and vaccines
ISSN: 2055-0936
Titre abrégé: Trop Dis Travel Med Vaccines
Pays: England
ID NLM: 101674442
Informations de publication
Date de publication:
06 Apr 2021
06 Apr 2021
Historique:
received:
25
11
2020
accepted:
23
03
2021
entrez:
7
4
2021
pubmed:
8
4
2021
medline:
8
4
2021
Statut:
epublish
Résumé
Predictions have been made that Africa would be the most vulnerable continent to the novel Coronavirus disease 2019 (COVID-19). Interestingly, the spread of the disease in Africa seems to have been delayed and initially slower than in many parts of the world. Here we report on two cases of respiratory distress in our region before the official declaration of the disease in December 2019, cases which in the present times would be suspect of COVID-19. These two cases (one 55-year-old man and one 25-year-old woman) of acute respiratory distress secondary to atypical pneumonia were seen in Bukavu, in Eastern Democratic Republic of the Congo (DRC), between September and December 2019. One patient had returned from China and the other had close contacts with travellers from China in the 2 weeks prior to the onset of symptoms. In either case, the aetiology could not be accurately determined. However, the two cases presented a clinical picture (progressive dyspnoea, preceded by dry cough and fever) and laboratory changes (procalcitonin within the normal range, slight inflammation, and lymphopenia) compatible with a viral infection. The chest X-ray series of the first patient showed lesions (reticulations, ground glass, and nodules ≤6 mm) similar to those currently found in COVID-19 patients. In addition, unlike the 25-year-old female patient who had no comorbidity, the 55-year-old male patient who had hypertension as comorbidity, developed a more severe acute respiratory distress which progressed to death. These cases bring to the attention the fact that COVID-19-like syndromes may have already been present in the region months before the official beginning of the pandemic. This also brings to question whether a prior presence of the disease or infections with related virus may account for the delayed and less extensive development of the pandemic in the region.
Sections du résumé
BACKGROUND
BACKGROUND
Predictions have been made that Africa would be the most vulnerable continent to the novel Coronavirus disease 2019 (COVID-19). Interestingly, the spread of the disease in Africa seems to have been delayed and initially slower than in many parts of the world. Here we report on two cases of respiratory distress in our region before the official declaration of the disease in December 2019, cases which in the present times would be suspect of COVID-19.
CASE PRESENTATION
METHODS
These two cases (one 55-year-old man and one 25-year-old woman) of acute respiratory distress secondary to atypical pneumonia were seen in Bukavu, in Eastern Democratic Republic of the Congo (DRC), between September and December 2019. One patient had returned from China and the other had close contacts with travellers from China in the 2 weeks prior to the onset of symptoms. In either case, the aetiology could not be accurately determined. However, the two cases presented a clinical picture (progressive dyspnoea, preceded by dry cough and fever) and laboratory changes (procalcitonin within the normal range, slight inflammation, and lymphopenia) compatible with a viral infection. The chest X-ray series of the first patient showed lesions (reticulations, ground glass, and nodules ≤6 mm) similar to those currently found in COVID-19 patients. In addition, unlike the 25-year-old female patient who had no comorbidity, the 55-year-old male patient who had hypertension as comorbidity, developed a more severe acute respiratory distress which progressed to death.
CONCLUSION
CONCLUSIONS
These cases bring to the attention the fact that COVID-19-like syndromes may have already been present in the region months before the official beginning of the pandemic. This also brings to question whether a prior presence of the disease or infections with related virus may account for the delayed and less extensive development of the pandemic in the region.
Identifiants
pubmed: 33823942
doi: 10.1186/s40794-021-00134-6
pii: 10.1186/s40794-021-00134-6
pmc: PMC8022307
doi:
Types de publication
Journal Article
Langues
eng
Pagination
9Références
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Am J Trop Med Hyg. 2020 Aug;103(2):564-569
pubmed: 32484156
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Trop Med Int Health. 2020 Mar;25(3):278-280
pubmed: 32052514
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
Infect Dis Clin North Am. 2010 Mar;24(1):7-25
pubmed: 20171542
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Ann Clin Biochem. 2021 Mar;58(2):95-101
pubmed: 33103442
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
Int J Infect Dis. 2020 Oct;99:266-268
pubmed: 32771632
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Chest. 2020 Jul;158(1):195-205
pubmed: 32224074
J Leukoc Biol. 2020 Jul;108(1):17-41
pubmed: 32534467
Laryngoscope. 2020 Jul;130(7):1787
pubmed: 32237238
Int J Antimicrob Agents. 2020 Jun;55(6):106006
pubmed: 32371096
Int J Infect Dis. 2021 Jan;102:577-583
pubmed: 33176202
Chem Senses. 2021 Jan 1;46:
pubmed: 33367502
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
N Engl J Med. 2009 Dec 24;361(26):2507-17
pubmed: 20007555
Science. 2020 Aug 7;369(6504):624-626
pubmed: 32764055
Clin Imaging. 2020 Aug;64:35-42
pubmed: 32302927
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
Lancet. 2020 Mar 14;395(10227):871-877
pubmed: 32087820
Rand Health Q. 2017 Jun 19;6(3):5
pubmed: 28845357
Int J Infect Dis. 2020 Apr;93:233-236
pubmed: 32119980
J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):e117-20
pubmed: 22772351
New Microbes New Infect. 2020 Nov;38:100760
pubmed: 32983542